» Articles » PMID: 21747034

Enlarged Substantia Nigra Hyperechogenicity and Risk for Parkinson Disease: a 37-month 3-center Study of 1847 Older Persons

Abstract

Objective: To evaluate whether enlarged substantia nigra hyperechogenicity (SN+) is associated with an increased risk for Parkinson disease (PD) in a healthy elderly population.

Design: Longitudinal 3-center observational study with 37 months of prospective follow-up.

Setting: Individuals 50 years or older without evidence of PD or any other neurodegenerative disease.

Participants: Of 1847 participants who underwent a full medical history, neurological assessment, and transcranial sonography at baseline, 1535 could undergo reassessment.

Main Outcome Measure: Incidence of new-onset PD in relation to baseline transcranial sonography status.

Results: There were 11 cases of incident PD during the follow-up period. In participants with SN+ at baseline, the relative risk for incident PD was 17.37 (95% confidence interval, 3.71-81.34) times higher compared with normoechogenic participants.

Conclusions: In this prospective study, we demonstrate for the first time a highly increased risk for PD in elderly individuals with SN+. Transcranial sonography of the midbrain may therefore be a promising primary screening procedure to define a risk population for imminent PD.

Citing Articles

Automatic Transcranial Sonography-Based Classification of Parkinson's Disease Using a Novel Dual-Channel CNXV2-DANet.

Kang H, Wang X, Sun Y, Li S, Sun X, Li F Bioengineering (Basel). 2024; 11(9).

PMID: 39329631 PMC: 11429106. DOI: 10.3390/bioengineering11090889.


[Treatment-resistant first-time depression in middle age].

Grotemeyer A, Kornhuber J, Spitzer P Nervenarzt. 2023; 94(9):855-858.

PMID: 37589782 PMC: 10499729. DOI: 10.1007/s00115-023-01530-3.


Motor cortical excitability and pre-supplementary motor area neurochemistry in healthy adults with substantia nigra hyperechogenicity.

Todd G, Rae C, Taylor J, Rogasch N, Butler J, Hayes M J Neurosci Res. 2022; 101(2):263-277.

PMID: 36353842 PMC: 10952673. DOI: 10.1002/jnr.25145.


A brief history of brain iron accumulation in Parkinson disease and related disorders.

Foley P, Hare D, Double K J Neural Transm (Vienna). 2022; 129(5-6):505-520.

PMID: 35534717 PMC: 9188502. DOI: 10.1007/s00702-022-02505-5.


Ultrasonographic Changes in Brain Hemodynamics in Patients with Parkinson's Disease and Risk Factors for Cerebrovascular Disease: A Pilot Study.

Brisson R, Fernandes R, Arruda J, Silva L, Lima M, Lucia Zuma Rosso A Parkinsons Dis. 2021; 2021:1713496.

PMID: 34650786 PMC: 8510819. DOI: 10.1155/2021/1713496.